In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

Allergan believes that by modifying facial expression and muscle contractions via Botox injections, there may also be a modification of brain circuitry at work in depression.

Regulators seem inclined to approve Allergan Inc's wrinkle drug Botox to prevent migraine headaches in millions of Americans, industry analysts said, based on information the drugmaker released on ...

Allergan is asking millennials if they're 'bo-curious,' and it's part of a plan to find a new generation of Botox customers By Lydia Ramsey Pflanzer Via Allergan Sep 17, 2018, 10:53 AM PT ...

A huge part of Allergan's patent-cliff immunity against other big pharmaceuticals is its blockbuster Botox, which has helped the company evade the patent problems facing others in the industry.

U.S. pharmaceutical giant Pfizer (PFE) and Irish rival Allergan (AGN) Monday announced a record-breaking $160-billion merger, the largest in health-care industry history and the biggest yet ...

Humira maker AbbVie is set to acquire Botox maker Allergan in another move toward consolidation for the pharmaceutical industry.

FORTUNE -- Allergan is in a tough spot. It manufactures Botox, the blockbuster cosmetic product that's made with a diluted form of the most potent toxin on the planet. America's favorite smile ...

In February, Allergan, best known as the manufacturer of Botox (Botulinum toxin), completed a $2.9-billion cash deal to acquire Branchburg, New Jersey–based LifeCell. The sale gives Allergan ...

Jim Cramer, the host of “Mad Money,” questions David Pyott, chief of Allergan, on the drug maker’s restructuring efforts and the sustainability of Valeant’s business model.

Actavis’s sixty-six-billion-dollar offer must have appealed to Allergan. Actavis’s promise to keep investing in research and development probably did, too.